SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 367 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,607 | +8.7% | 38 | +2.7% | 0.00% | – |
| Q2 2023 | $4,238 | -75.8% | 37 | -70.9% | 0.00% | -100.0% |
| Q1 2023 | $17,505 | +322.1% | 127 | +296.9% | 0.00% | – |
| Q4 2022 | $4,147 | -30.9% | 32 | -43.9% | 0.00% | -100.0% |
| Q3 2022 | $6,000 | -45.5% | 57 | -61.0% | 0.00% | 0.0% |
| Q2 2022 | $11,000 | -54.2% | 146 | -52.8% | 0.00% | -66.7% |
| Q1 2022 | $24,000 | -65.7% | 309 | -60.1% | 0.00% | -62.5% |
| Q4 2021 | $70,000 | -2.8% | 774 | -0.9% | 0.01% | -20.0% |
| Q3 2021 | $72,000 | +414.3% | 781 | +331.5% | 0.01% | +400.0% |
| Q2 2021 | $14,000 | +366.7% | 181 | +364.1% | 0.00% | – |
| Q1 2021 | $3,000 | -75.0% | 39 | -45.8% | 0.00% | -100.0% |
| Q4 2020 | $12,000 | +100.0% | 72 | +71.4% | 0.00% | +100.0% |
| Q3 2020 | $6,000 | -14.3% | 42 | -6.7% | 0.00% | -50.0% |
| Q2 2020 | $7,000 | -68.2% | 45 | -80.5% | 0.00% | -50.0% |
| Q1 2020 | $22,000 | +2100.0% | 231 | +1676.9% | 0.00% | – |
| Q4 2019 | $1,000 | -98.3% | 13 | -96.7% | 0.00% | -100.0% |
| Q2 2019 | $58,000 | +13.7% | 389 | -11.8% | 0.01% | 0.0% |
| Q1 2019 | $51,000 | – | 441 | +7250.0% | 0.01% | – |
| Q3 2018 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |